{"id":"W4382020994","doi":"10.1038/s41571-023-00785-8","title":"Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy","year":2023,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Fondation pour la Recherche Médicale; Horizon 2020 Framework Programme; Institut Universitaire de France; Stand Up To Cancer; Genentech; Labex Immuno-Oncology; National Institutes of Health; PharmaMar; University of Texas MD Anderson Cancer Center; Ligue Contre le Cancer; AstraZeneca; Institut National Du Cancer; Fonds de Recherche du Québec - Santé; Institut National de la Santé et de la Recherche Médicale; Exelixis; Sanofi; European Commission; Daiichi Sankyo Europe; National Cancer Institute; HORIZON EUROPE Framework Programme; Gilead Sciences; Melanoma Research Alliance; GlaxoSmithKline; Fondation ARC pour la Recherche sur le Cancer; Agence Nationale de la Recherche; Bristol-Myers Squibb; American Association for Cancer Research; Seerave Foundation","keywords":"Dysbiosis; Medicine; Gut flora; Clinical trial; Cancer; Biomarker; Metagenomics; Bioinformatics; Oncology; Computational biology; Immunology; Internal medicine; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.006584675,0.00125079,0.009873694,0.00057873,0.0001876686,0.00008234564,0.0008406623,0.007869433,0.0004895381],"category_scores_gemma":[0.002176254,0.0008422002,0.006851071,0.001420864,0.000476689,0.0001224819,0.0001249562,0.003965267,0.0003356739],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001553157,"about_ca_system_score_gemma":0.004583801,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005310497,"about_ca_topic_score_gemma":0.000178748,"domain_scores_codex":[0.9898286,0.001796701,0.00535307,0.001722107,0.0004045528,0.0008949585],"domain_scores_gemma":[0.9911729,0.003539003,0.003247119,0.001327746,0.0003484614,0.0003648422],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001163699,0.0003318923,0.000001708238,0.0131217,0.003438567,0.00003775466,0.00001295024,4.623721e-8,0.0004046705,0.00005471548,0.1759229,0.8055094],"study_design_scores_gemma":[0.004057735,0.002201243,0.00001235262,0.0195727,0.004171091,0.0001162895,0.000006018735,0.000007619164,0.000004301308,0.0000348534,0.9690072,0.0008085869],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001030342,0.9759668,0.00002144018,0.002523079,0.009851483,0.01067423,0.0002487439,0.0003144771,0.0003895065],"genre_scores_gemma":[0.000001289729,0.9723742,0.001509607,0.01098292,0.006413823,0.003212122,0.001590411,0.0004382379,0.003477375],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8047009,"threshold_uncertainty_score":0.9994029,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3343139125727195,"score_gpt":0.5517493436111188,"score_spread":0.2174354310383994,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}